Clinical trial
Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible…
NCT00327808 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00327808 |
|---|---|
| Title | Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma |
| Official title | Multi-Center, Randomized, Double-Blind, Repeated Doses Study to Evaluate the Safety, Tolerability and Pharmacodynamic Activity of Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | TPI-1020, budesonide |
| Enrollment | 27 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | May 19, 2006 |
| Last update posted | Dec 3, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: